XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 3,965 $ 10,365 $ 12,527 $ 20,388
General and administrative 1,595 2,108 5,229 6,511
Total operating expenses 5,560 12,473 17,756 26,899
Loss from operations (5,560) (12,473) (17,756) (26,899)
Interest income and other expense, net 425 225 1,204 336
Sublease income - related party   147 56 439
Loss from equity method investment (865) (2,730) (3,880) (5,367)
Net loss $ (6,000) $ (14,831) $ (20,376) $ (31,491)
Net loss per share, basic $ (0.12) $ (0.32) $ (0.43) $ (0.68)
Net loss per share, diluted $ (0.12) $ (0.32) $ (0.43) $ (0.68)
Shares used to compute net loss per share, basic 48,971,246 46,553,511 47,683,792 46,553,511
Shares used to compute net loss per share, diluted 48,971,246 46,553,511 47,683,792 46,553,511
Other comprehensive loss:        
Unrealized gain (loss) on marketable securities $ 5 $ 5 $ 45 $ (77)
Cumulative foreign currency translation adjustment (80) (1,537) (925) (2,985)
Comprehensive loss $ (6,075) $ (16,363) $ (21,256) $ (34,553)